MarketPeel
Insider Trading Intelligence
Pricing
…
SN

Seshadri Neervannan

TARS
CHIEF OPERATING OFFICER · TARSUS PHARMACEUTICALS, INC. · CIK 0001827584
FILING MIX · LIFETIME38%/62%
BUYS
16
SELLS
26
TOTAL VALUE
$2.15M
COMPANIES
1
ACTIVE SINCE
Jan 2021
HOLDINGS NOW
82,791
AVG SELL PX
$57.64
TRADE KIND
SHOWING 42 / 42
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 18 pending
Forward-return performance of every backtestable P/S trade by Seshadri Neervannan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+46.67%-0.47%+0.15%-0.62%+0.90%—
14d15+40.00%+1.61%+0.82%+0.78%+3.56%—
30d15+46.67%+3.88%+2.12%+1.76%+0.95%—
60d15+53.33%+8.91%+6.77%+3.00%+2.96%—
90d15+60.00%+11.47%+10.57%+3.29%-15.39%—
180d15(5 pending)+0.00%+18.70%+14.32%+4.38%+5.82%—
1y15(5 pending)+0.00%+110.50%+25.89%+84.60%+106.45%—
2y15(8 pending)+0.00%+263.86%+44.79%+219.06%+232.15%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TARS · 82,791 shares · as of Mar 20, 2026
024,27648,55272,82897,10420222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 16 buys / 26 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,989$66.75$199.5K82,791Mar 20, 2026Mar 24, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
4,589$67.00$307.5K85,780Mar 19, 2026Mar 19, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
3,610$68.71$248.0K90,369Mar 18, 2026Mar 19, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
3,125$69.42$216.9K93,979Mar 17, 2026Mar 19, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
5,097——0Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Operating Officer
26,287——97,104Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
8,020——16,040Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
5,022——15,067Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
8,148——8,148Mar 15, 2026Mar 17, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
17,161——17,161Mar 5, 2026Mar 9, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
27,310——27,310Mar 5, 2026Mar 9, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
8,366$76.67$641.4K70,817Mar 4, 2026Mar 5, 2026 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Gift
475——475Dec 16, 2025Dec 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALEGRANT
Gift
950——79,183Dec 16, 2025Dec 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
2,435$50.11$122.0K79,682Mar 20, 2025Mar 20, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
2,543$47.40$120.5K82,117Mar 19, 2025Mar 20, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
2,605$46.29$120.6K84,660Mar 18, 2025Mar 20, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Operating Officer
21,264——87,265Mar 15, 2025Mar 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
8,019——24,060Mar 15, 2025Mar 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
8,148——16,296Mar 15, 2025Mar 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
5,097——5,097Mar 15, 2025Mar 18, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,628——30,628Mar 5, 2025Mar 7, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,089——20,089Mar 5, 2025Mar 7, 2025 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
4,879$30.60$149.3K64,767Mar 18, 2024Mar 19, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
5,097——10,194Mar 15, 2024Mar 19, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
8,148——24,444Mar 15, 2024Mar 19, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Operating Officer
13,245——69,646Mar 15, 2024Mar 19, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,079——32,079Mar 7, 2024Mar 11, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
47,500——47,500Mar 7, 2024Mar 11, 2024 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
390$12.15$4.7K54,696Mar 23, 2023Mar 23, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
379$12.64$4.8K55,086Mar 22, 2023Mar 23, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
372$12.89$4.8K55,465Mar 21, 2023Mar 23, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
380$12.61$4.8K55,837Mar 20, 2023Mar 21, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
360$13.28$4.8K56,217Mar 17, 2023Mar 21, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
357$13.43$4.8K56,577Mar 16, 2023Mar 17, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASE
Chief Operating Officer
5,097——56,934Mar 15, 2023Mar 17, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
SALE
Chief Operating Officer
5,097——15,291Mar 15, 2023Mar 17, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,592——32,592Mar 8, 2023Mar 10, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
48,116——48,116Mar 8, 2023Mar 10, 2023 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
69,498——69,498Mar 9, 2022Mar 11, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,388——20,388Mar 9, 2022Mar 11, 2022 ↗View →
TARS
TARSUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
61,499——61,499Jan 7, 2021Jan 8, 2021 ↗View →
Other insiders · TARS
Loading peer insiders…
About this filer
CIK 0001827584
ROLE
Chief Operating Officer
PRIMARY
TARS
COMPANIES
1
ACTIVE SINCE
Jan 2021
MARKETPEEL · /INSIDER/0001827584DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback